Unknown

Dataset Information

0

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.


ABSTRACT: Dengue virus (DENV) induces strong T and B cell responses upon infection. Hence, it is difficult to determine the contribution of cell-mediated immunity alone in the long lasting protection against DENV infection and disease. Numerous CD4+ and CD8+ T cell epitopes have been identified, mainly in the non-structural proteins of DENV. Taking into account the immunogenicity and peptide sequence conservation among the different DENV serotypes, a minimal DENV antigen, called DENV1-NS, has been designed. This antigen is enriched in conserved and highly antigenic epitopes located in the NS3, NS4B, and NS5 regions of DENV1. To evaluate the ability of the DENV1-NS poly-epitope to express the antigenic peptides in the context of different HLA class I molecules, we established its in vivo immunogenicity by measuring, after DNA immunization and electroporation, the activation of DENV-specific CD8 T cells in transgenic mice expressing the human HLA-A*0201, -A*2402, -B*0702, and -B*3502 class I alleles. We then engineered a lipid nanoparticle (LNP) encapsulated modified mRNA vaccine encoding DENV1-NS and tested immunogenicity and protection in these human HLA class I transgenic mice, after transient blockade of the interferon (IFN) type I receptor. Significant protection was observed, after two injections of the mRNA vaccine. Collectively, these data strongly support the development of T cell-based vaccines targeting immunodominant T cell epitopes that generate potent virus-specific T cell responses conferring immunity against DENV infection.

SUBMITTER: Roth C 

PROVIDER: S-EPMC6598640 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.

Roth Claude C   Cantaert Tineke T   Colas Chloé C   Prot Matthieu M   Casadémont Isabelle I   Levillayer Laurine L   Thalmensi Jessie J   Langlade-Demoyen Pierre P   Gerke Christiane C   Bahl Kapil K   Ciaramella Giuseppe G   Simon-Loriere Etienne E   Sakuntabhai Anavaj A  

Frontiers in immunology 20190621


Dengue virus (DENV) induces strong T and B cell responses upon infection. Hence, it is difficult to determine the contribution of cell-mediated immunity alone in the long lasting protection against DENV infection and disease. Numerous CD4+ and CD8+ T cell epitopes have been identified, mainly in the non-structural proteins of DENV. Taking into account the immunogenicity and peptide sequence conservation among the different DENV serotypes, a minimal DENV antigen, called DENV1-NS, has been designe  ...[more]

Similar Datasets

| S-EPMC2638843 | biostudies-literature
| S-EPMC2626739 | biostudies-literature
| S-EPMC2628559 | biostudies-literature
| S-EPMC3058316 | biostudies-literature
| S-EPMC3546861 | biostudies-literature
| S-EPMC5499006 | biostudies-literature
| S-EPMC4347545 | biostudies-literature
| S-EPMC538543 | biostudies-literature
| S-EPMC2884037 | biostudies-literature
| S-EPMC5047630 | biostudies-literature